1. Home
  2. SOTK vs CTSO Comparison

SOTK vs CTSO Comparison

Compare SOTK & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOTK
  • CTSO
  • Stock Information
  • Founded
  • SOTK 1975
  • CTSO 1997
  • Country
  • SOTK United States
  • CTSO United States
  • Employees
  • SOTK N/A
  • CTSO N/A
  • Industry
  • SOTK Industrial Machinery/Components
  • CTSO Medical/Dental Instruments
  • Sector
  • SOTK Technology
  • CTSO Health Care
  • Exchange
  • SOTK Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • SOTK 52.1M
  • CTSO 61.7M
  • IPO Year
  • SOTK 1987
  • CTSO N/A
  • Fundamental
  • Price
  • SOTK $3.91
  • CTSO $0.94
  • Analyst Decision
  • SOTK Hold
  • CTSO Buy
  • Analyst Count
  • SOTK 1
  • CTSO 2
  • Target Price
  • SOTK N/A
  • CTSO $5.50
  • AVG Volume (30 Days)
  • SOTK 28.0K
  • CTSO 121.4K
  • Earning Date
  • SOTK 10-14-2025
  • CTSO 11-06-2025
  • Dividend Yield
  • SOTK N/A
  • CTSO N/A
  • EPS Growth
  • SOTK N/A
  • CTSO N/A
  • EPS
  • SOTK 0.09
  • CTSO N/A
  • Revenue
  • SOTK $20,606,116.00
  • CTSO $36,107,520.00
  • Revenue This Year
  • SOTK $0.56
  • CTSO $11.93
  • Revenue Next Year
  • SOTK $8.95
  • CTSO $21.22
  • P/E Ratio
  • SOTK $43.45
  • CTSO N/A
  • Revenue Growth
  • SOTK N/A
  • CTSO 20.18
  • 52 Week Low
  • SOTK $3.23
  • CTSO $0.71
  • 52 Week High
  • SOTK $6.05
  • CTSO $1.61
  • Technical
  • Relative Strength Index (RSI)
  • SOTK 64.13
  • CTSO 45.75
  • Support Level
  • SOTK $3.82
  • CTSO $0.94
  • Resistance Level
  • SOTK $4.23
  • CTSO $1.04
  • Average True Range (ATR)
  • SOTK 0.18
  • CTSO 0.06
  • MACD
  • SOTK 0.07
  • CTSO 0.00
  • Stochastic Oscillator
  • SOTK 65.59
  • CTSO 46.58

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: